Literature DB >> 8173758

The role of the leukocyte adhesion molecules VLA-4, LFA-1, and Mac-1 in allergic airway responses in the rat.

H A Rabb1, R Olivenstein, T B Issekutz, P M Renzi, J G Martin.   

Abstract

Chronic airway inflammation is involved in the pathogenesis of asthma. The leukocyte adhesion molecules VLA-4 of the beta 1 integrin family, and LFA-1 and Mac-1 of the beta 2 family have a demonstrated role in leukocyte-endothelial adherence and may play a role in airway inflammation in asthma. We studied the effects of blocking VLA-4 (CD49d/CD29) and both LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) airway responses and inflammation in rats. BN rats were sensitized with ovalbumin (OA) subcutaneously and were challenged 14 d later with aerosolized OA. Twelve rats were treated prior to challenge with anti-rat VLA-4 monoclonal antibody (mAb), 10 rats received both anti-LFA-1 and anti-Mac-1 mAb, and 14 rats received a control mAb. The pulmonary resistance (RL) was measured for 8 h after challenge. The inflammatory response was evaluated by bronchoalveolar lavage (BAL) and by measuring the lung and airway inflammatory cells retrieved by enzymative dispersion. The early response was significantly decreased in both the anti-VLA-4 group (131% baseline RL) and the anti-LFA-1/Mac-1 group (118%; p < 0.05) compared with the control group (202%). The late response was also significantly decreased in both the anti-VLA-4 (3.7) and anti-LFA-1/Mac-1 (2.6) groups compared with the control group (19.7). The significant differences in bronchoalveolar lavage were a decrease in neutrophils in the LFA-1/Mac-1 group and an increase in macrophages in the anti-VLA-4 group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8173758     DOI: 10.1164/ajrccm.149.5.8173758

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  22 in total

1.  Chlamydial colonization of multiple mucosae following infection by any mucosal route.

Authors:  L L Perry; S Hughes
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

2.  A small molecule, orally active, alpha4beta1/alpha4beta7 dual antagonist reduces leukocyte infiltration and airway hyper-responsiveness in an experimental model of allergic asthma in Brown Norway rats.

Authors:  Julio Cortijo; María-Jesús Sanz; Arantxa Iranzo; José Luis Montesinos; Yafa Naim Abu Nabah; José Alfón; Luis A Gómez; Manuel Merlos; Esteban J Morcillo
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

Review 3.  The pathophysiologic role of alpha 4 integrins in vivo.

Authors:  R R Lobb; M E Hemler
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

4.  Lymphocyte recruitment and the kinetics of adhesion receptor expression during the pulmonary immune response to particulate antigen.

Authors:  F M Wolber; J L Curtis; A M Milik; T Fields; G D Seitzman; K Kim; S Kim; J Sonstein; L M Stoolman
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

5.  An emerging paradigm shift on the role of leukocyte adhesion molecules.

Authors:  H Rabb; J G Martin
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

6.  Antibody to VLA-4, but not to L-selectin, protects neuronal M2 muscarinic receptors in antigen-challenged guinea pig airways.

Authors:  A D Fryer; R W Costello; B L Yost; R R Lobb; T F Tedder; D A Steeber; B S Bochner
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

7.  Expression and targeting of lymphocyte function-associated antigen 1 (LFA-1) on white blood cells for treatment of allergic asthma.

Authors:  Anukriti Gupta; Vanessa Espinosa; Lindsey E Galusha; Vahid Rahimian; Katie L Miro; Amariliz Rivera-Medina; Chinnaswamy Kasinathan; Eugenio Capitle; Helen A Aguila; Scott C Kachlany
Journal:  J Leukoc Biol       Date:  2014-10-23       Impact factor: 4.962

Review 8.  Treatment of delayed-type hypersensitivity with inhibitors of the VLA-4 integrin.

Authors:  S Tamraz; T Arrhenius; A Chiem; M J Forrest; F C Gaeta; Y B He; J Lei; A Maewal; M L Phillips; L W Vollger
Journal:  Springer Semin Immunopathol       Date:  1995

Review 9.  Therapeutic approaches to asthma based on VLA-4 integrin and its counter receptors.

Authors:  W J Metzger
Journal:  Springer Semin Immunopathol       Date:  1995

10.  Alpha-4/beta-1 and alpha-L/beta-2 integrins mediate cytokine induced lung leukocyte-epithelial adhesion and injury.

Authors:  L A Parmley; N D Elkins; M A Fini; Y-E Liu; J E Repine; R M Wright
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.